About the Company
Science
Medications
Careers
Press Center
Pharmacovigilance
+7 (495) 684-43-33
РУ EN
+7 (495) 684-43-33
  • About the Company
  • Science
  • Medications
  • Careers
  • Press Center
  • Pharmacovigilance

    • Company News

    Материа Медика
    04.07.2022

    The SIRIUS-2021 space experiment completed in Moscow, with Materia Medica Holding acting as a partner
    Материа Медика
    17.06.2022

    Raphamin acclaimed as best at Smartpharma Awards 2022
    Материа Медика
    18.11.2021

    Rengalin and Ergoferon praised as Products of the Year
    Материа Медика
    03.11.2021

    Innovative antiviral medication Raphamin gets registered in Russia

    Материа Медика
    29.10.2021

    Cough medicine Rengalin recognized Brand of the Year No. 1 in Russia

    Материа Медика
    30.01.2020

    The use of medicines - ANAFERON, ANAFERON FOR CHILDREN, ERGOFERON - as part of complex therapy and prevention of infections caused by coronaviruses
    Материа Медика
    10.01.2018

    An international observational program has shown that Ergoferon is effective in the treatment of ARVIs and influenza at early and later stages

    Company News 1 - 7 из 56
     Начало | Пред. | 1 2 3 4 5 | След. | Конец